Plain-English translation of NCT07059845 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help treat ovarian cancer. Researchers want to find the best dose and the best combination of this medication with other standard ovarian cancer treatments. The study will also carefully monitor how safe this medication is and how well it works.
Ovarian cancer is a serious disease that causes many deaths worldwide, and current treatments don't work for everyone. This trial is exploring whether this new treatment approach could offer hope to patients who have already tried other therapies or are starting treatment for the first time.
You likely qualify if…
You likely don't qualify if…
You would visit a hospital or clinic regularly throughout the study, which lasts approximately 2.5 to 3.5 years depending on which treatment group you join. During visits, you would receive the medication as an intravenous infusion (through a vein), have blood tests drawn, and undergo imaging scans to monitor your cancer. You should be prepared for more frequent medical appointments and assessments than you might receive with standard care alone.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States